UroGen Pharma Ltd.
URGN | NASDAQ
$43.20
-$0.05 (-0.12%)
At close: Sep 21, 2026, 4:00 PM ET
$44.20
+$1 (+2.31%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 110.75M | 171.99M | 95M | 55.41M | 44.36M | 52.86M |
Short-Term Investments | 9.71M | 64.7M | 41.97M | 44.56M | 44.78M | 49.15M |
Long-Term Investments | 177K | 5.02M | 4.5M | n/a | 675K | 1.89M |
Other Long-Term Assets | 5.16M | 765K | 2.26M | 2.96M | 1.53M | 289K |
Receivables | 33.08M | 20.3M | 15.44M | 12.7M | 11.72M | 7.05M |
Inventory | 16.46M | 9.23M | 5.67M | 4.33M | 4.83M | 1.96M |
Other Current Assets | 16.02M | 9.92M | 11.1M | 11.91M | 1.23M | 1.23M |
Total Current Assets | 186.02M | 276.14M | 169.19M | 128.91M | 114.39M | 115.62M |
Property-Plant & Equipment | 9.09M | 3.79M | 2.36M | 3.75M | 3.15M | 4.2M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 14.43M | 9.58M | 9.13M | 6.71M | 5.36M | 6.39M |
Total Assets | 200.46M | 285.71M | 178.31M | 135.62M | 119.75M | 122.01M |
Account Payables | 12.14M | 10.93M | 6.51M | 5.53M | 5.79M | 3.27M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 18.7M | 18.52M | 14.67M | 11.53M | 10.28M | 11.41M |
Total Current Liabilities | 46.42M | 45.95M | 31.21M | 23.92M | 22.38M | 21.44M |
Long-Term Debt | 122.21M | 121.73M | 98.55M | 97.54M | n/a | n/a |
Other Long-Term Liabilities | 131.18M | 125.18M | 112.92M | 98.92M | 85.71M | n/a |
Total Long-Term Liabilities | 259.51M | 248.57M | 212.31M | 201.06M | 88.95M | 4.21M |
Total Liabilities | 305.93M | 294.51M | 243.52M | 224.98M | 111.33M | 25.65M |
Total Debt | 128.33M | 123.39M | 99.4M | 99.12M | 398K | 1.5M |
Book Value | -105.47M | -8.8M | -65.21M | -89.36M | 8.41M | 96.36M |
Book Value Per Share | -2.19 | -0.21 | -2.26 | -3.92 | 0.38 | 4.42 |
Common Stock | 133K | 115K | 89K | 63K | 61K | 60K |
Retained Earnings | -959.72M | -806.22M | -679.35M | -577.1M | -467.32M | -356.5M |
Comprehensive Income | 19K | 56K | 12K | -107K | -25K | 271K |
Shareholders Equity | -105.47M | -8.8M | -65.21M | -89.36M | 8.41M | 96.36M |
Total Investments | 9.89M | 69.72M | 46.47M | 44.56M | 45.45M | 51.05M |
Add to Watchlist
Select watchlists to add or remove URGN